Published October 16, 2025 | Version v1
Journal article Open

PR3-ANCA associated vasculitis with rapidly progressive glomerulonephritis (RPGN): an uncommon cause of rapidly developing renal failure

Description

Abstract

PR3-ANCA-associated vasculitis is a rare autoimmune disease characterized by systemic inflammation, primarily affecting the respiratory tract but occasionally leading to rapidly progressive glomerulonephritis (RPGN). We present the case of a 64-year-old male with diabetes, hypertension, and COPD, who developed RPGN and pulmonary manifestation, initially manifesting as frothy urine, pedal edema, and dyspnoea. Diagnostic evaluation revealed positive PR3-ANCA, proteinuria, hematuria, and significant renal pathology, necessitating hemodialysis and immunosuppressive therapy with cyclophosphamide . This case underscores the need for early recognition and tailored management of PR3-ANCA vasculitis to improve patient outcomes.

 

Files

CR1.pdf

Files (758.5 kB)

Name Size Download all
md5:60a8bde084fe6728499c7c3e3b4d186f
758.5 kB Preview Download

Additional details

References

  • Bantis K, Stangou MJ, Kalpakidis S, Nikolaidou C, Lioulios G, Mitsoglou Z, Iatridi F, Fylaktou A, Papagianni A. Different types of ANCA determine different clinical phenotypes and outcome in ANCA-associated vasculitis (AAV). Frontiers in Medicine. 2022 Jan 21;8:783757.
  • Wiik A. What you should know about PR3-ANCA: an introduction. Arthritis Research & Therapy. 2000 Jun;2:1-3.
  • Falde SD, Fussner LA, Tazelaar HD, O'Brien EK, Lamprecht P, Konig MF, Specks U. Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. The Lancet Rheumatology. 2024 May 1;6(5):e314-27.
  • Bantis K, Stangou MJ, Kalpakidis S, Nikolaidou C, Lioulios G, Mitsoglou Z, Iatridi F, Fylaktou A, Papagianni A. Different types of ANCA determine different clinical phenotypes and outcome in ANCA-associated vasculitis (AAV). Frontiers in Medicine. 2022 Jan 21;8:783757.
  • Qasim A, Patel JB. ANCA-Associated Vasculitis. InStatPearls [Internet] 2024 Aug 31. StatPearls Publishing.
  • Rout P, Naik RH, Leslie SW. Rapidly progressive glomerulonephritis. InStatPearls [Internet] 2024 Jun 7. StatPearls Publishing.
  • Wallace ZS, Stone JH. Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?. Frontiers in Immunology. 2019 Dec 6;10:2855.
  • Wallace ZS, Stone JH. Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?. Frontiers in Immunology. 2019 Dec 6;10:2855.
  • Gu Y, Zhang T, Zhu W, Han Y, Shi J. Prevalence and characteristics of bronchiectasis in ANCA-associated vasculitis: A systematic review and meta-analysis. Archives of Rheumatology. 2024 Feb 6;39(3):488.
  • Tan MH, Jayne D. Top ten tips in managing ANCA vasculitis. Clinical Kidney Journal. 2024 Nov 30:sfae389.
  • Hirata M, Miyazawa H, Morino J, Kaneko S, Minato S, Katsunori Y, Ishii H, Kitano T, Ito K, Hirai K, Oda T. A case report of PR-3-ANCA-positive glomerulonephritis with histological features of GPA associated with infectious endocarditis. Medicine. 2021 Aug 13;100(32):e26905.
  • Wallace ZS, Stone JH. Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?. Frontiers in Immunology. 2019 Dec 6;10:2855.